The table below shows Cocrystal Pharma, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
$2.01M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$5.05M
$12.54M
$15.17M
$12.39M
$8.79M
$6.03M
SG&A
$3.96M
COCP annual revenue (10-K history)
Cocrystal Pharma, Inc. reported annual revenue of $2.01M for fiscal year 2020. That is down 69.3% from $6.56M in fiscal 2019. Figures come from the company's audited annual reports as filed with the SEC.